Previous Article | Next Article ![]()
Journal of Clinical Microbiology, August 1998, p. 2200-2204, Vol. 36, No. 8
Department of Medicine and Department of
Microbiology and Immunology, Division of Infectious Diseases,
Albert Einstein College of Medicine, Bronx, New York
Received 24 February 1998/Returned for modification 17 April
1998/Accepted 1 May 1998
Cryptococcus neoformans serotypes A and D are
responsible for the overwhelming majority of infections in patients
with AIDS. The genetic relationship between the serotypes is poorly
understood, but there are significant differences in the epidemiology
and clinical presentation of serotype A and D infections. We evaluated the genetic relationship between reference C. neoformans
strains belonging to serotypes A and D by analyzing their
URA5 sequences and restriction fragment length
polymorphisms (RFLPs) with the C. neoformans repetitive
element 1 (CNRE-1) probe. The results were compared to those previously
obtained for isolates from Brazil and New York City by the same typing
methods, and dendrograms were generated. Serotype A and D strains
produced distinct RFLP patterns consistent with their separation into
two major clusters in the dendrogram generated on the basis of RFLP
data. Similarly, serotype A and D strains clustered independently on
the basis of the nucleotide sequences of their URA5 genes.
Pairwise comparisons revealed average numbers of nucleotide differences
within serotypes A and D of 3.0 ± 1.7 and 7.2 ± 3.4, respectively (P < 0.0001), and between serotypes A
and D of 41.9 ± 2.7. In summary, our results indicate
phylogenetic differences between the two serotypes of C. neoformans var. neoformans and suggest that these
serotypes could probably be considered different varieties of C. neoformans.
Cryptococcus neoformans
is an encapsulated yeast that can cause severe meningoencephalitis in
immunocompromised patients, especially those with AIDS. On the basis of
the antigenic composition of the capsular polysaccharide, C. neoformans has been divided into four serotypes: serotypes A, B,
C, and D. The four serotypes have been further divided into two
varieties, C. neoformans var. neoformans
(serotypes A and D) and C. neoformans var. gattii
(serotypes B and C), on the basis of biochemical, morphological and
genetic characteristics (22, 24). C. neoformans
var. neoformans is primarily the etiologic agent of
cryptococcosis in patients with AIDS, and serotype A comprises the
overwhelming majority of clinical isolates. Infections due to strains
belonging to serotype D are more prevalent in certain geographic areas,
including France, Italy, and Denmark (2, 12, 24). In France,
serotype D causes 21% of cases of cryptococcosis (11, 13).
Serotype D infections are more likely than serotype A infections to
occur in older patients, to result in skin involvement, and to be
associated with corticosteroid therapy (11, 13).
The genetic relationship between isolates classified as serotypes A and
D is uncertain. Guého et al. (17) found a relatively large phylogenetic distance between serotypes A and D by analysis of
partial 26S rRNA sequences. Meyer et al. (23) used PCR
fingerprinting analysis to demonstrate that strains of serotypes A and
D could be distinguished from each other. Similarly, Varma and
Kwon-Chung (31) reported the isolation of a DNA probe
(UT-4p) that was able to discriminate between these serotypes. Brandt
et al. (4) demonstrated that serotypes A and D could be
distinguished by their multilocus enzyme electrophoresis profile.
Serotypes A and D also show consistent differences in their
electrophoretic karyotypes (26, 27). Hence, there is
evidence that serotypes A and D belong to genetically distinct groups,
but they remain within a single varietal classification because
occasional strains of A and D isolates have been successfully mated
(20). The uncertainty regarding the genetic relationship
between serotype A and D strains is compounded by extensive genetic
heterogeneity for strains grouped within a serotype.
The field of cryptococcal research is relatively small, and independent
groups tend to work with different strains. This raises the concern
that findings with a particular strain may not be generalizable. In
this study we used two molecular typing techniques, DNA fingerprinting
with the C. neoformans repetitive element 1 (CNRE-1) probe
and analysis of the nucleotide sequence of the URA5 gene, to
investigate the genetic relationship between reference C. neoformans strains belonging to serotypes A and D. For the purpose
of this study we defined a reference strain as one that has been used
in more than one study and/or more than one laboratory. Our results
indicate phylogenetic differences between the two serotypes of C. neoformans var. neoformans and the genetic relationship between commonly used laboratory strains.
C. neoformans strains.
A detailed list of the
reference strains used in this study is presented in Table
1. Clinical and environmental isolates from Brazil (designated C and E followed by a number, respectively) were described previously (16). Clinical strains from New
York (J isolates) were also reported earlier (6). All
strains were kept in 50% glycerol in a freezer at
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Genetic Relationship between Cryptococcus
neoformans var. neoformans Strains of Serotypes A
and D

![]()
ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
80°C and were
grown overnight on Sabouraud's broth at 30°C for DNA isolation.
TABLE 1.
Details for some C. neoformans var.
neoformans strains used in this studya
Serotyping. The serotype classifications for the reference strains are listed in Table 1. Recent isolates from Brazil (isolates C5, C7, C24, C25, C31, C33, RJ1, RJ2, E3, E4, E5, E6, E9, and E12) and New York (isolates J15, J17, J19, J24, J25, and J26) were serotyped by the slide agglutination test with sera containing cryptococcal antigen factors 1, 5, 6, 7, and 8 (Iatron Laboratories, Inc., Tokyo, Japan). On the basis of the patterns of agglutination, the results were interpreted as follows: serotypes A, B, C, D, and AD reacted with antigen factors 1, 7; 1, 5; 1, 6; 1, 8; and 1, 7, 8, respectively.
The reactivity of monoclonal antibody (MAb) 13F1 with the recent isolates from Brazil and New York was also examined by indirect immunofluorescence (IF). Previously, we reported that IF with MAb 13F1 discriminates between most serotype A and D strains by producing annular and punctate binding patterns, respectively (9). IF studies were performed as described previously (9). Briefly, stationary-phase cells were washed and incubated with MAb 13F1 at 10 µg/ml for 2 h at room temperature. MAb binding was detected with fluorescein isothiocyanate-labeled goat anti-mouse immunoglobulin M (Southern Biotechnology, Birmingham, Ala.). Samples were viewed with a Zeiss (Thornwood, N.Y.) Axiophot microscope equipped with a fluorescein isothiocyanate filter. All the reference strains listed in Table 1 were previously examined by IF (9).CNRE-1 RFLP analysis.
All strains were typed by Southern
blot analysis with CNRE-1 as described previously (16).
Briefly, genomic DNA was extracted from protoplasts (16) and
was digested with SacI (Boehringer Mannheim, Indianapolis,
Ind.), and the resulting fragments were probed with CNRE-1 labeled with
[
-32P]dCTP. The bands were visualized by
autoradiography.
DNA molecular weight
marker (Boehringer Mannheim), and Dice coefficients of similarity
(number of shared bands × 2/total number of fragments in the two
strains) were calculated for each pair of strains compared, generating
a matrix of similarity coefficients. Dendrograms based on these
matrices were then generated by the unweighted pair-group method of
average linkage (28). When two patterns were compared, a
match was recorded if the normalized molecular size of the fragment in
the first pattern was within a window of ±1.5% of the molecular size
of a fragment in the second pattern. The CNRE-1 RFLP patterns of
Brazilian and New York City isolates reported earlier (10,
16) were also scanned and compared to those of the reference
strains.
URA5 nucleotide sequencing. URA5 DNA was amplified from genomic DNA by PCR as described previously (16) and was cloned into the pCR 2.1 vector of the TA cloning system (Invitrogen, San Diego, Calif.). Escherichia coli transformants were selected on plates containing 50 µg of kanamycin per ml, and plasmid DNA was purified with Midi-Prep columns (Qiagen, Chatsworth, Calif.). The insert was sequenced in the DNA Sequencing Facility of the Albert Einstein College of Medicine with automated sequencing instrument models ABI373A and ABI377 (Perkin-Elmer, Foster City, Calif.). Samples were analyzed by fluorescent cycle sequencing with dye-labeled primers.
The URA5 sequences obtained from the reference strains were compared with sequences previously obtained for seven New York City clinical isolates (GenBank accession no. L38582 to L38858, respectively), 10 Brazilian clinical and environmental isolates (GenBank accession no. U67723 to U67732, respectively), isolate B-3501 (GenBank accession no. M34606), and C. neoformans var. gattii (GenBank accession no. M93026). All sequences were first aligned by using Clustal V (18), and phylogenies were then estimated by use of the DNAPENNY (branch and bound parsimony), CONSENSE, and SEQBOOT programs of the PHYLIP package, version 3.5c (15).Nucleotide sequence accession numbers. The URA5 DNA sequences of the reference strains have been deposited in GenBank, and the accession numbers are listed in Table 1.
| |
RESULTS |
|---|
|
|
|---|
Serotyping. Of the 20 recent isolates from Brazil and New York, all but isolates J25 and J26 presented agglutination patterns consistent with their assignment to serotype A. Isolates J25 and J26 showed positive reactions with antigenic factors 1, 7, and 8 characteristic of serotype AD. IF with MAb 13F1 produced an annular pattern of binding typical of serotype A strains for all recent isolates, thus confirming the results obtained with the sera containing cryptococcal antigen factors.
CNRE-1 RFLP analysis. To determine whether the DNA fingerprints of the reference strains correlated with their serotypic status, Southern hybridization with the CNRE-1 probe was performed with serotype A and D isolates of C. neoformans var. neoformans. As seen in Fig. 1, hybridization of CNRE-1 to SacI-digested genomic DNA from serotype A isolates generated complex patterns of bands ranging from 11 to 16 restriction fragments with various intensities. A strongly hybridizing band at approximately 3.5 kb was present in all serotype A isolates. No two serotype A isolates had identical CNRE-1 RFLPs, although the dendrogram generated on the basis of the RFLP data grouped isolates 24064 and 184 together because it considered a band position tolerance of 1.5% (Fig. 2). This dendrogram also showed that isolates H99 and 145 were highly related, with 76% similarity. CNRE-1 hybridized to fewer bands and with a lower intensity for serotype D isolates (Fig. 1). The number of restriction fragments produced ranged from 5 to 11. Isolates 3501 and 3502 were very similar, clustering together with 76% similarity. Overall, serotype A and D isolates produced distinct RFLP patterns consistent with their separation into two major clusters (clusters a and b), as demonstrated in the dendrogram presented in Fig. 2. All recent isolates from Brazil and New York were placed among the reference serotype A strains.
|
|
URA5 sequence analysis. Partial sequences of the URA5 gene for serotype A and D strains are presented in Fig. 3 along with the partial sequence of strain 3501 (14). Isolates 24067 and J9 had identical sequences, as did isolates J11 and H99. Among the isolates belonging to serotype D, the number of nucleotide substitutions averaged 7.2 ± 3.4 (n = 15 pairwise comparisons). The URA5 genes from strains J21 and J22 showed the greatest number of base differences (between 9 and 10 substitutions) compared to the numbers for the other serotype D isolates. The nucleotide sequences of the serotype A isolates differed from each other by an average of 3.0 ± 1.7 base differences (n = 15 pairwise comparisons). The average number of URA5 base differences obtained by pairwise comparisons between serotype A and D isolates was 41.9 ± 2.7 (n = 30). Parsimony analysis (with bootstrapping) of these sequences identified a consensus tree that confirmed the dendrogram obtained from the CNRE-1 RFLP data, indicating that isolates of serotypes A and D clustered independently (Fig. 4). Remarkably, the separate clusters obtained for these serotypes occurred in 100% of the bootstrap replicates. Again, recently isolated strains from Brazil and New York were placed in the cluster that contained reference serotype A isolates.
|
|
| |
DISCUSSION |
|---|
|
|
|---|
To better understand the genetic relationship between serotypes A and D of C. neoformans var. neoformans, we have determined the CNRE-1 RFLP profiles and the nucleotide sequences of the URA5 genes from a set of reference strains. The CNRE-1 RFLP profiles of serotype A strains were more complex than those of serotype D strains, with average band numbers of 14 ± 2.1 and 8.2 ± 2.4 bands, respectively. Spitzer and Spitzer (29) also observed that CNRE-1 hybridized less intensely and to fewer bands for a serotype D isolate. In our study the CNRE-1 RFLP patterns for serotype D strains were also less intense than those for serotype A strains. This difference in intensity most likely represents a quantitative difference in CNRE-1 copy number in the genome and suggests that serotype D isolates contain fewer repetitive elements within one restriction fragment.
Genetic differences between serotypes A and D were also demonstrated by the nucleotide sequence of the URA5 gene. Within a serotype, the base replacements occurred mostly at the same nucleotide position. The only exceptions were isolates J21 and J22, which showed a few substitutions (5 of 22) that were more typical of serotype A isolates than D isolates (Fig. 3). The RFLP patterns of strains J21 and J22 also contained more bands than those of the other serotype D isolates tested (data not shown). Interestingly, these strains are classified as serotype D, but it was later shown for isolate J22 that it has a novel GXM triad structure not found in serotype A or D isolates (8). Studies with a MAb that discriminates between serotype A and D isolates on the basis of the fluorescence pattern revealed that strain J22 is like serotype A isolates (9). Hence, strain J22 appears to be an unusual strain with certain unique characteristics.
Overall, our results indicate that serotypes A and D segregated into two groups which appear to be phylogenetically distant from each other, as demonstrated by the independent clusters observed in the trees generated from RFLP and sequencing data. Our findings are in agreement with those of Guého et al. (17), who also found a relative phylogenetic difference between serotypes A and D on the basis of the sequence of the 26S large subunit of rRNA. We were also able to detect phylogenetic distance between serotypes A and D by investigating a gene that has been shown to be highly polymorphic among cryptococcal isolates (5, 6). In addition, a comparison between the reference isolates and those from Brazil and New York suggested that the observed phylogenetic distance of serotype A and serotype D isolates is independent of the geographic background of the isolate.
Analysis of several commonly used C. neoformans laboratory strains revealed significant phylogenetic differences. Among the reference serotype A strains, strains H99 and 145 and strains 24064 and 184 were most closely related by both URA5 sequence and CNRE-1 RFLPs. Nevertheless, each of the isolates was distinguishable by DNA typing, suggesting the possibility of different biological traits. Considering the existence of significant genetic differences among isolates classified within a serotype and among reference strains, one should be cautious in generalizing conclusions on the basis of data obtained for one strain. Our results suggest that it may be prudent to include both serotype A and D strains when conducting biological studies with C. neoformans.
The taxonomy of C. neoformans and its teleomorph, Filobasidiella neoformans, has been the subject of several studies. Initially, two different species were recognized: C. neoformans (serotypes A and D) and its sexual state, F. neoformans (20), and C. bacillispora (serotypes B and C) and its teleomorph, F. bacillispora (21). Further taxonomic studies with Cryptococcus species and their teleomorphs reclassified these two species into C. neoformans var. neoformans and C. neoformans var. gattii on the basis of successful interspecific crosses and DNA relatedness (1, 22). Although the current classification of C. neoformans remains at the varietal status, more recent studies have brought into question this proposed scheme. Boekhout et al. (3) demonstrated that C. neoformans var. neoformans and C. neoformans var. gattii differ in their genetic makeups and may represent separate species. Genetic differences between serotypes A and D, as described in this report and by others (see the introduction), provide additional evidence that the taxonomy of C. neoformans may need to be reinvestigated. Consistent with this, phenotypic differences between serotypes A and D have also been reported. These differences include the chemical structure of the capsular polysaccharide (7, 19) and qualitative and quantitative antigenic dissimilarities among serotype A and D strains (9). In one study, it was suggested that serotypes D and A may not have the same virulence, tropism, and/or ecological niche (13).
Recently, we have proposed that the population structure of C. neoformans is clonal on the basis of analysis of URA5
sequences, electrophoretic karyotypes, and CNRE-1 RFLPs
(16). The results of this study are consistent with that
proposal and extend it by suggesting the divergence of serotype A and D
strains along different lineages. C. neoformans mating types
a and
have been described for serotype D strains, but no
serotype A a strain has ever been recovered from clinical or
environmental sources. C. neoformans strains which are
efficient mating pairs have all been serotype D. The divergence of
serotype A and D lineages combined with a high mating efficiency
restricted to serotype D suggests that future population structure
studies should consider strains of serotype A and D separately.
In summary, our findings revealed genetic unrelatedness between serotypes A and D of C. neoformans and indicate that these serotypes could probably be considered different varieties of C. neoformans. Our results suggest that C. neoformans var. gattii and C. neoformans var. neoformans could be regarded as separate species, as originally proposed, and serotypes A and D and serotypes B and C would then represent different varieties of each species. Additional genetic studies will be necessary to further define the exact genetic relationship between the serotypes of C. neoformans, including those belonging to serotypes B and C.
| |
ACKNOWLEDGMENTS |
|---|
A.C. is supported by a Burroughs Wellcome Fund Development Therapeutics Award and National Institutes of Health grants AI-22774 and AI-13342.
We thank J. W. Taylor for careful review of and helpful comments on the manuscript.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Albert Einstein College of Medicine, 1300 Morris Park Ave., Golding Building, Room 701, Bronx, NY 10461. Phone: (718) 430-4259. Fax: (718) 430-8701. E-mail: casadeva{at}aecom.yu.edu.
Present address: Department of Pharmacology, Cornell University
Medical College, New York, NY 10021.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Aulakh, H. S., S. E. Straus, and K. J. Kwon-Chung. 1981. Genetic relatedness of Filobasidiella neoformans (Cryptococcus neoformans) and Filobasidiella bacillispora (Cryptococcus bacillispora) as determined by DNA base composition and sequence homology studies. Int. J. Syst. Bacteriol. 31:97-103. |
| 2. |
Bennett, J. E.,
K. J. Kwon-Chung, and D. Howard.
1984.
Epidemiologic differences among serotypes of Cryptococcus neoformans.
Am. J. Epidemiol.
105:582-586 |
| 3. |
Boekhout, T.,
A. van Belkum,
A. C. Leenders,
H. A. Verbrugh,
P. Mukamurangwa,
D. Swinne, and W. A. Scheffers.
1997.
Molecular typing of Cryptococcus neoformans: taxonomic and epidemiological aspects.
Int. J. Syst. Bacteriol.
47:432-442 |
| 4. |
Brandt, M. E.,
S. L. Bragg, and R. W. Pinner.
1993.
Multilocus enzyme typing of Cryptococcus neoformans.
J. Clin. Microbiol.
31:2819-2823 |
| 5. |
Casadevall, A.,
L. F. Freundlich,
L. Marsh, and M. Scharff.
1992.
Extensive allelic variation in Cryptococcus neoformans.
J. Clin. Microbiol.
30:1080-1084 |
| 6. | Chen, F., B. P. Currie, L. C. Chen, S. G. Spitzer, E. D. Spitzer, and A. Casadevall. 1995. Genetic relatedness of Cryptococcus neoformans clinical isolates with the repetitive DNA probe CNRE-1. J. Clin. Microbiol. 33:2818-2822[Abstract]. |
| 7. |
Cherniak, R., and J. B. Sundstrom.
1994.
Polysaccharide antigens of the capsule of Cryptococcus neoformans.
Infect. Immun.
62:1507-1512 |
| 8. | Cherniak, R., L. C. Morris, T. Belay, E. D. Spitzer, and A. Casadevall. 1995. Variation in the structure of glucuronoxylomannan in isolates from patients with recurrent cryptococcal meningitis. Infect. Immun. 63:1899-1905[Abstract]. |
| 9. |
Cleare, W., and A. Casadevall.
1998.
The different binding patterns of two immunoglobulin M monoclonal antibodies to Cryptococcus neoformans serotype A and D strains correlate with serotype classification and differences in functional assays.
Clin. Diagn. Lab. Immunol.
5:125-129 |
| 10. |
Currie, B. P.,
L. F. Freundlich, and A. Casadevall.
1994.
Restriction fragment length polymorphism analysis of Cryptococcus neoformans isolates from environmental (pigeon excreta) and clinical sources in New York City.
J. Clin. Microbiol.
32:1188-1192 |
| 11. |
Dromer, F.,
A. Varma,
A. Ronin,
S. Mathoulin, and B. Dupont.
1994.
Molecular typing of Cryptococcus neoformans serotype D clinical isolates.
J. Clin. Microbiol.
32:2364-2371 |
| 12. | Dromer, F., S. Mathoulin, B. Dupont, A. Laporte, and the French Cryptococcosis Study Group. 1996. Epidemiology of cryptococcosis in France: a 9-year survey (1985-1993). Clin. Infect. Dis. 23:82-90[Medline]. |
| 13. | Dromer, F., S. Mathoulin, B. Dupont, L. Letenneur, O. Ronin, and the French Cryptococcosis Study Group. 1996. Individual and environmental factors associated with infection due to Cryptococcus neoformans serotype D. Clin. Infect. Dis. 23:91-96[Medline]. |
| 14. |
Edman, J. C., and K. J. Kwon-Chung.
1990.
Isolation of the URA5 gene from Cryptococcus neoformans var. neoformans and its use as a selective marker for transformation.
Mol. Cell. Biol.
10:4538-4544 |
| 15. | Felsenstein, J. 1993. PHYLIP (Phylogeny Inference Package), version 3.5c. Distributed by the author. Department of Genetics, University of Washington, Seattle. |
| 16. | Franzot, S. P., J. S. Hamdan, B. P. Currie, and A. Casadevall. 1997. Molecular epidemiology of Cryptococcus neoformans in Brazil and the United States: evidence for both local genetic differences and a global clonal population structure. J. Clin. Microbiol. 35:2243-2251[Abstract]. |
| 17. | Guého, E., L. Improvisi, R. Christen, and G. S. de Hoog. 1993. Phylogenetic relationships of Cryptococcus neoformans and some related basidiomycetous yeasts determined from partial large subunit rRNA sequences. Antonie Leeuwenhoek 63:175-189[Medline]. |
| 18. |
Higgins, D. G.,
A. J. Bleasby, and R. Fuchs.
1997.
CLUSTALV: improved software for multiple sequence alignment.
Comput. Appl. Biosci.
8:189-191 |
| 19. | Ikeda, R., S. Nishimura, A. Nishikawa, and T. Shinoda. 1996. Production of agglutinating monoclonal antibody against antigen 8 specific for Cryptococcus neoformans serotype D. Clin. Diagn. Lab. Immunol. 3:89-92[Abstract]. |
| 20. | Kwon-Chung, K. J. 1975. A new genus Filobasidiella, the perfect state of Cryptococcus neoformans. Mycologia 67:1197-1200. |
| 21. | Kwon-Chung, K. J. 1976. A new species of Filobasidiella, the perfect state of Cryptococcus neoformans B and C serotypes. Mycologia 68:942-946. |
| 22. | Kwon-Chung, K. J., J. E. Bennett, and J. C. Rhodes. 1982. Taxonomic studies on Filobasidiella species and their anamorphs. Antonie Leeuwenhoek 48:25-38[Medline]. |
| 23. |
Meyer, W.,
T. G. Mitchell,
E. Z. Freedman, and R. Vilgalys.
1993.
Hybridization probes for conventional DNA fingerprinting used as single primers in the polymerase chain reaction to distinguish strains of Cryptococcus neoformans.
J. Clin. Microbiol.
31:2274-2280 |
| 24. |
Mitchell, T. G., and J. R. Perfect.
1995.
Cryptococcosis in the era of AIDS 100 years after the discovery of Cryptococcus neoformans.
Clin. Microbiol. Rev.
8:515-548[Abstract].
|
| 25. |
Murphy, J. W., and G. C. Cozad.
1972.
Immunological unresponsiveness induced by cryptococcal polysaccharide assayed by the hemolytic plate technique.
Infect. Immun.
5:896-901 |
| 26. |
Perfect, J. R.,
B. B. Magee, and P. T. Magee.
1989.
Separation of chromosomes of Cryptococcus neoformans by pulsed-field gel electrophoresis.
Infect. Immun.
57:2624-2627 |
| 27. | Polacheck, I., and G. A. Lebens. 1989. Electrophoretic karyotype of the pathogenic yeast Cryptococcus neoformans. J. Gen. Microbiol. 134:1037-1041. |
| 28. | Romesburg, H. C. 1990. Cluster analysis for researchers. Robert E. Krieger Publishing Company, Malabar, Fla. |
| 29. |
Spitzer, E. D., and S. G. Spitzer.
1992.
Use of a dispersed repetitive DNA element to distinguish clinical isolates of Cryptococcus neoformans.
J. Clin. Microbiol.
30:1094-1097 |
| 30. | Spitzer, E. D., S. G. Spitzer, L. F. Freundlich, and A. Casadevall. 1993. Persistence of initial infection in recurrent Cryptococcus neoformans meningitis. Lancet 341:595-596[Medline]. |
| 31. |
Varma, A., and K. J. Kwon-Chung.
1992.
DNA probe for strain typing of Cryptococcus neoformans.
J. Clin. Microbiol.
30:2960-2967 |
| 32. | Wilson, D. E., J. E. Bennett, and J. W. Bailey. 1968. Serologic grouping of Cryptococcus neoformans. Proc. Soc. Exp. Biol. Med. 127:820-823[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|